norm?... expect tradeoffs are the norm... so expect this question is answered. How valuable to NVS is an extra board seat? They can pretty much do as they wish w/ IDIX. The new board member's position / status w/ NVS is no doubt a positive for IDIX. Looking forward to positive news on IDX 184 and IDX 899 (GSK)